Contracts › 75F40126C00065
75F40126C00065: Eo 14398 Baa Identification and Performance Assessment of Medical Devices in Electronic Health Record Data Development of a Transparent and Repeatable Framework to Enhance Medical Device Integration in Real World Evidence Generation
Awarded to Rutgers the State University of New Jersey by Food and Drug Administration (FDA).
$6.5Mobligated
$35.2Mpotential value
23 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40126C00065 |
|---|---|
| Awardee | Rutgers the State University of New Jersey |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NJ |
| Offers received | 257 |
| Period of performance | 15 September 2026 to 23 September 2027 |
| Potential end | 23 September 2031 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 12 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record